We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$11.3B
AUM Growth
+$1.04B
Cap. Flow
-$52M
Cap. Flow %
-0.46%
Top 10 Hldgs %
47.48%
Holding
572
New
12
Increased
35
Reduced
164
Closed
54

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
SNPS icon
Synopsys
SNPS
+$11.8M
3
TMO icon
Thermo Fisher Scientific
TMO
+$9.22M
4
DKS icon
Dick's Sporting Goods
DKS
+$9.09M
5
VEEV icon
Veeva Systems
VEEV
+$8.73M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$10.7M
3
INTU icon
Intuit
INTU
+$7.3M
4
PGR icon
Progressive
PGR
+$5.02M
5
TJX icon
TJX Companies
TJX
+$4.86M

Sector Composition

Rank Sector Weight
1 Technology 40.61%
2 Healthcare 15.23%
3 Consumer Discretionary 10.81%
4 Financials 10.75%
5 Communication Services 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUS icon
326
Metallus
MTUS
$900M
$123K ﹤0.01%
8,000
DVN icon
327
Devon Energy
DVN
$48.5B
$122K ﹤0.01%
3,835
TRP icon
328
TC Energy
TRP
$65.8B
$120K ﹤0.01%
2,455
TW icon
329
Tradeweb Markets
TW
$22B
$119K ﹤0.01%
810
-1,200
-60% -$167K
ENPH icon
330
Enphase Energy
ENPH
$5.33B
$118K ﹤0.01%
2,970
-530
-15% -$24.5K
BTI icon
331
British American Tobacco
BTI
$124B
$117K ﹤0.01%
2,475
XEL icon
332
Xcel Energy
XEL
$49.4B
$116K ﹤0.01%
1,700
GEHC icon
333
GE HealthCare
GEHC
$33.1B
$115K ﹤0.01%
1,552
-6
-0.4% -$418
PRGS icon
334
Progress Software
PRGS
$1.78B
$115K ﹤0.01%
1,800
ESGU icon
335
iShares ESG Aware MSCI USA ETF
ESGU
$18.5B
$113K ﹤0.01%
837
IWR icon
336
iShares Russell Mid-Cap ETF
IWR
$58.1B
$111K ﹤0.01%
1,209
MOS icon
337
The Mosaic Company
MOS
$7.1B
$109K ﹤0.01%
3,000
FDX icon
338
FedEx
FDX
$78.7B
$108K ﹤0.01%
475
VST icon
339
Vistra
VST
$49B
$107K ﹤0.01%
550
WY icon
340
Weyerhaeuser
WY
$17.9B
$103K ﹤0.01%
4,000
EML icon
341
Eastern Company
EML
$155M
$103K ﹤0.01%
4,500
UBCP icon
342
United Bancorp
UBCP
$90M
$100K ﹤0.01%
6,917
BNY
343
Bank of New York Mellon
BNY
$110B
$100K ﹤0.01%
1,100
VWO icon
344
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$98.2K ﹤0.01%
1,986
RIVN icon
345
Rivian
RIVN
$23.2B
$97.7K ﹤0.01%
7,107
VRT icon
346
Vertiv
VRT
$112B
$96.3K ﹤0.01%
750
SBR
347
Sabine Royalty Trust
SBR
$1.06B
$95.8K ﹤0.01%
1,437
TTE icon
348
TotalEnergies
TTE
$192B
$95.5K ﹤0.01%
1,555
IXUS icon
349
iShares Core MSCI Total International Stock ETF
IXUS
$60.9B
$95.3K ﹤0.01%
1,233
NTES icon
350
NetEase
NTES
$78.2B
$94.2K ﹤0.01%
700

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Loring Wolcott & Coolidge Fiduciary Advisors held 572 positions worth $11.3B, up 10% from $10.3B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2025 filing shows 12 new, 35 increased, 164 reduced and 54 closed positions. Its largest new stake was Capital One: 17,701 shares worth $3.77M. The largest sale was Mastercard, an estimated $22.6M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2025 buy was Capital One: 17,701 shares worth $3.77M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NVIDIA in Q2 2025, an estimated $18.8M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2025 reduction was Mastercard, cutting an estimated $22.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $3.31M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $11.3B portfolio in Q2 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 12 new positions and closed 54 in Q2 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 10% quarter-over-quarter to $11.3B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.